Logo

MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 401k Plan overview

Plan NameMEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN
Plan identification number 001

MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

MEDICAL PRODUCTS LABORATORIES, INC. has sponsored the creation of one or more 401k plans.

Company Name:MEDICAL PRODUCTS LABORATORIES, INC.
Employer identification number (EIN):231875679
NAIC Classification:311300
NAIC Description: Sugar and Confectionery Product Manufacturing

Form 5500 Filing Information

Submission information for form 5500 for 401k plan MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012023-01-01
0012022-01-01
0012021-01-01
0012020-01-01
0012019-01-01
0012019-01-01
0012018-01-01
0012017-01-01DAVID WAXLER
0012016-01-01DAVID WAXLER
0012015-01-01DAVID WAXLER DAVID WAXLER2016-10-17
0012014-01-01DAVID WAXLER
0012013-01-01DAVID WAXLER
0012012-01-01DAVID WAXLER
0012011-01-01DAVID WAXLER
0012009-01-01DAVID WAXLER

Plan Statistics for MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN

401k plan membership statisitcs for MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN

Measure Date Value
2023: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2023 401k membership
Total participants, beginning-of-year2023-01-01243
Total number of active participants reported on line 7a of the Form 55002023-01-01218
Number of retired or separated participants receiving benefits2023-01-017
Number of other retired or separated participants entitled to future benefits2023-01-0131
Total of all active and inactive participants2023-01-01256
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2023-01-010
Total participants2023-01-01256
Number of participants with account balances2023-01-01107
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2023-01-012
2022: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year2022-01-01210
Total number of active participants reported on line 7a of the Form 55002022-01-01249
Number of retired or separated participants receiving benefits2022-01-016
Number of other retired or separated participants entitled to future benefits2022-01-0118
Total of all active and inactive participants2022-01-01273
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2022-01-010
Total participants2022-01-01273
Number of participants with account balances2022-01-01104
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2022-01-013
2021: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year2021-01-01208
Total number of active participants reported on line 7a of the Form 55002021-01-01187
Number of retired or separated participants receiving benefits2021-01-016
Number of other retired or separated participants entitled to future benefits2021-01-0117
Total of all active and inactive participants2021-01-01210
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2021-01-010
Total participants2021-01-01210
Number of participants with account balances2021-01-0192
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2021-01-012
2020: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year2020-01-01166
Total number of active participants reported on line 7a of the Form 55002020-01-01178
Number of retired or separated participants receiving benefits2020-01-014
Number of other retired or separated participants entitled to future benefits2020-01-0117
Total of all active and inactive participants2020-01-01199
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2020-01-010
Total participants2020-01-01199
Number of participants with account balances2020-01-0186
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2020-01-011
2019: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year2019-01-01182
Total number of active participants reported on line 7a of the Form 55002019-01-01138
Number of retired or separated participants receiving benefits2019-01-014
Number of other retired or separated participants entitled to future benefits2019-01-0121
Total of all active and inactive participants2019-01-01163
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2019-01-010
Total participants2019-01-01163
Number of participants with account balances2019-01-0189
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2019-01-014
2018: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year2018-01-01185
Total number of active participants reported on line 7a of the Form 55002018-01-01148
Number of retired or separated participants receiving benefits2018-01-014
Number of other retired or separated participants entitled to future benefits2018-01-0117
Total of all active and inactive participants2018-01-01169
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2018-01-010
Total participants2018-01-01169
Number of participants with account balances2018-01-0190
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2018-01-011
2017: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year2017-01-01191
Total number of active participants reported on line 7a of the Form 55002017-01-01145
Number of retired or separated participants receiving benefits2017-01-012
Number of other retired or separated participants entitled to future benefits2017-01-0132
Total of all active and inactive participants2017-01-01179
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2017-01-010
Total participants2017-01-01179
Number of participants with account balances2017-01-01101
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2017-01-013
2016: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year2016-01-01205
Total number of active participants reported on line 7a of the Form 55002016-01-01175
Number of retired or separated participants receiving benefits2016-01-011
Number of other retired or separated participants entitled to future benefits2016-01-0123
Total of all active and inactive participants2016-01-01199
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2016-01-010
Total participants2016-01-01199
Number of participants with account balances2016-01-0190
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2016-01-015
2015: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2015 401k membership
Total participants, beginning-of-year2015-01-01191
Total number of active participants reported on line 7a of the Form 55002015-01-01193
Number of retired or separated participants receiving benefits2015-01-011
Number of other retired or separated participants entitled to future benefits2015-01-0121
Total of all active and inactive participants2015-01-01215
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2015-01-010
Total participants2015-01-01215
Number of participants with account balances2015-01-0191
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2015-01-010
2014: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2014 401k membership
Total participants, beginning-of-year2014-01-01152
Total number of active participants reported on line 7a of the Form 55002014-01-01158
Number of retired or separated participants receiving benefits2014-01-012
Number of other retired or separated participants entitled to future benefits2014-01-0122
Total of all active and inactive participants2014-01-01182
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2014-01-010
Total participants2014-01-01182
Number of participants with account balances2014-01-0192
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2014-01-011
2013: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2013 401k membership
Total participants, beginning-of-year2013-01-01187
Total number of active participants reported on line 7a of the Form 55002013-01-01144
Number of retired or separated participants receiving benefits2013-01-010
Number of other retired or separated participants entitled to future benefits2013-01-011
Total of all active and inactive participants2013-01-01145
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2013-01-010
Total participants2013-01-01145
Number of participants with account balances2013-01-0121
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2013-01-011
2012: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2012 401k membership
Total participants, beginning-of-year2012-01-01172
Total number of active participants reported on line 7a of the Form 55002012-01-01156
Number of retired or separated participants receiving benefits2012-01-010
Number of other retired or separated participants entitled to future benefits2012-01-0119
Total of all active and inactive participants2012-01-01175
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2012-01-010
Total participants2012-01-01175
Number of participants with account balances2012-01-0167
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2012-01-012
2011: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2011 401k membership
Total participants, beginning-of-year2011-01-01159
Total number of active participants reported on line 7a of the Form 55002011-01-01138
Number of retired or separated participants receiving benefits2011-01-010
Number of other retired or separated participants entitled to future benefits2011-01-0122
Total of all active and inactive participants2011-01-01160
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2011-01-010
Total participants2011-01-01160
Number of participants with account balances2011-01-0166
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2011-01-013
2009: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year2009-01-01114
Total number of active participants reported on line 7a of the Form 55002009-01-01114
Number of retired or separated participants receiving benefits2009-01-010
Number of other retired or separated participants entitled to future benefits2009-01-0122
Total of all active and inactive participants2009-01-01136
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2009-01-010
Total participants2009-01-01136
Number of participants with account balances2009-01-0163
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2009-01-010

Financial Data on MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN

Measure Date Value
2023 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2023 401k financial data
Total unrealized appreciation/depreciation of assets2023-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2023-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2023-12-31$9,972
Total income from all sources (including contributions)2023-12-31$1,929,886
Total loss/gain on sale of assets2023-12-31$0
Total of all expenses incurred2023-12-31$324,020
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2023-12-31$277,867
Expenses. Certain deemed distributions of participant loans2023-12-31$7,145
Total contributions o plan (from employers,participants, others, non cash contrinutions)2023-12-31$494,305
Value of total assets at end of year2023-12-31$8,377,211
Value of total assets at beginning of year2023-12-31$6,781,317
Total of administrative expenses incurred including professional, contract, advisory and management fees2023-12-31$39,008
Total interest from all sources2023-12-31$11,057
Total dividends received (eg from common stock, registered investment company shares)2023-12-31$205,382
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2023-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2023-12-31$205,382
Was this plan covered by a fidelity bond2023-12-31Yes
Value of fidelity bond cover2023-12-31$500,000
If this is an individual account plan, was there a blackout period2023-12-31No
Were there any nonexempt tranactions with any party-in-interest2023-12-31No
Contributions received from participants2023-12-31$397,347
Participant contributions at end of year2023-12-31$203,775
Participant contributions at beginning of year2023-12-31$185,263
Participant contributions at end of year2023-12-31$13,363
Participant contributions at beginning of year2023-12-31$13,742
Income. Received or receivable in cash from other sources (including rollovers)2023-12-31$76,893
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2023-12-31$2,224
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2023-12-31$9,972
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2023-12-31No
Value of net income/loss2023-12-31$1,605,866
Value of net assets at end of year (total assets less liabilities)2023-12-31$8,377,211
Value of net assets at beginning of year (total assets less liabilities)2023-12-31$6,771,345
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2023-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2023-12-31No
Were any leases to which the plan was party in default or uncollectible2023-12-31No
Investment advisory and management fees2023-12-31$32,177
Value of interest in registered invesment companies (eg mutual funds) at end of year2023-12-31$7,585,253
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2023-12-31$6,067,618
Interest on participant loans2023-12-31$11,057
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2023-12-31$574,127
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2023-12-31$511,675
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2023-12-31$511,675
Net investment gain/loss from registered investment companies (e.g. mutual funds)2023-12-31$1,219,142
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2023-12-31No
Was there a failure to transmit to the plan any participant contributions2023-12-31No
Has the plan failed to provide any benefit when due under the plan2023-12-31No
Contributions received in cash from employer2023-12-31$20,065
Employer contributions (assets) at end of year2023-12-31$693
Employer contributions (assets) at beginning of year2023-12-31$795
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2023-12-31$277,867
Did the plan have assets held for investment2023-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2023-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2023-12-31No
Opinion of an independent qualified public accountant for this plan2023-12-31Unqualified
Accountancy firm name2023-12-31CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN2023-12-31232428965
2022 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets2022-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$9,972
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total income from all sources (including contributions)2022-12-31$-1,050,876
Total loss/gain on sale of assets2022-12-31$0
Total of all expenses incurred2022-12-31$221,010
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-12-31$172,540
Value of total corrective distributions2022-12-31$9,972
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-12-31$445,610
Value of total assets at end of year2022-12-31$6,781,317
Value of total assets at beginning of year2022-12-31$8,043,231
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-12-31$38,498
Total interest from all sources2022-12-31$6,009
Total dividends received (eg from common stock, registered investment company shares)2022-12-31$222,816
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-12-31No
Was this plan covered by a fidelity bond2022-12-31Yes
Value of fidelity bond cover2022-12-31$500,000
If this is an individual account plan, was there a blackout period2022-12-31No
Were there any nonexempt tranactions with any party-in-interest2022-12-31No
Contributions received from participants2022-12-31$404,639
Participant contributions at end of year2022-12-31$185,263
Participant contributions at beginning of year2022-12-31$123,491
Participant contributions at end of year2022-12-31$13,742
Participant contributions at beginning of year2022-12-31$12,446
Income. Received or receivable in cash from other sources (including rollovers)2022-12-31$20,271
Value of other receiveables (less allowance for doubtful accounts) at end of year2022-12-31$2,224
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2022-12-31$721
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2022-12-31$9,972
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Value of net income/loss2022-12-31$-1,271,886
Value of net assets at end of year (total assets less liabilities)2022-12-31$6,771,345
Value of net assets at beginning of year (total assets less liabilities)2022-12-31$8,043,231
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2022-12-31No
Were any leases to which the plan was party in default or uncollectible2022-12-31No
Investment advisory and management fees2022-12-31$38,498
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-12-31$6,067,618
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-12-31$7,422,687
Interest on participant loans2022-12-31$6,009
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2022-12-31$511,675
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2022-12-31$483,134
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2022-12-31$483,134
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-12-31$-1,725,311
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-12-31No
Was there a failure to transmit to the plan any participant contributions2022-12-31No
Has the plan failed to provide any benefit when due under the plan2022-12-31No
Contributions received in cash from employer2022-12-31$20,700
Employer contributions (assets) at end of year2022-12-31$795
Employer contributions (assets) at beginning of year2022-12-31$752
Income. Dividends from common stock2022-12-31$222,816
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-12-31$172,540
Did the plan have assets held for investment2022-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-12-31No
Opinion of an independent qualified public accountant for this plan2022-12-31Unqualified
Accountancy firm name2022-12-31CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN2022-12-31232428965
2021 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets2021-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total income from all sources (including contributions)2021-12-31$1,582,415
Total loss/gain on sale of assets2021-12-31$0
Total of all expenses incurred2021-12-31$158,655
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$120,721
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$427,328
Value of total assets at end of year2021-12-31$8,043,231
Value of total assets at beginning of year2021-12-31$6,619,471
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$37,934
Total interest from all sources2021-12-31$6,454
Total dividends received (eg from common stock, registered investment company shares)2021-12-31$186,551
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2021-12-31$186,551
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$500,000
If this is an individual account plan, was there a blackout period2021-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2021-12-31$0
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$405,332
Participant contributions at end of year2021-12-31$123,491
Participant contributions at beginning of year2021-12-31$167,385
Participant contributions at end of year2021-12-31$12,446
Participant contributions at beginning of year2021-12-31$11,998
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$1,251
Value of other receiveables (less allowance for doubtful accounts) at end of year2021-12-31$721
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2021-12-31$817
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Value of net income/loss2021-12-31$1,423,760
Value of net assets at end of year (total assets less liabilities)2021-12-31$8,043,231
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$6,619,471
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Investment advisory and management fees2021-12-31$37,934
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$7,422,687
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2021-12-31$5,983,109
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2021-12-31$483,134
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2021-12-31$455,460
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2021-12-31$455,460
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2021-12-31$6,454
Net investment gain/loss from registered investment companies (e.g. mutual funds)2021-12-31$962,082
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31No
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Contributions received in cash from employer2021-12-31$20,745
Employer contributions (assets) at end of year2021-12-31$752
Employer contributions (assets) at beginning of year2021-12-31$702
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$120,721
Did the plan have assets held for investment2021-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31No
Opinion of an independent qualified public accountant for this plan2021-12-31Unqualified
Accountancy firm name2021-12-31CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN2021-12-31222428965
2020 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets2020-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total income from all sources (including contributions)2020-12-31$1,416,801
Total loss/gain on sale of assets2020-12-31$0
Total of all expenses incurred2020-12-31$165,409
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2020-12-31$131,763
Total contributions o plan (from employers,participants, others, non cash contrinutions)2020-12-31$384,860
Value of total assets at end of year2020-12-31$6,619,471
Value of total assets at beginning of year2020-12-31$5,368,079
Total of administrative expenses incurred including professional, contract, advisory and management fees2020-12-31$33,646
Total interest from all sources2020-12-31$5,856
Total dividends received (eg from common stock, registered investment company shares)2020-12-31$170,747
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2020-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2020-12-31$170,747
Was this plan covered by a fidelity bond2020-12-31Yes
Value of fidelity bond cover2020-12-31$500,000
If this is an individual account plan, was there a blackout period2020-12-31No
Were there any nonexempt tranactions with any party-in-interest2020-12-31No
Contributions received from participants2020-12-31$366,196
Participant contributions at end of year2020-12-31$167,385
Participant contributions at beginning of year2020-12-31$120,609
Participant contributions at end of year2020-12-31$11,998
Value of other receiveables (less allowance for doubtful accounts) at end of year2020-12-31$817
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2020-12-31$1,245
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2020-12-31$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Value of net income/loss2020-12-31$1,251,392
Value of net assets at end of year (total assets less liabilities)2020-12-31$6,619,471
Value of net assets at beginning of year (total assets less liabilities)2020-12-31$5,368,079
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2020-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2020-12-31No
Were any leases to which the plan was party in default or uncollectible2020-12-31No
Investment advisory and management fees2020-12-31$33,646
Value of interest in registered invesment companies (eg mutual funds) at end of year2020-12-31$5,983,109
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2020-12-31$4,725,686
Interest on participant loans2020-12-31$5,856
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2020-12-31$455,460
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2020-12-31$520,539
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2020-12-31$520,539
Net investment gain/loss from registered investment companies (e.g. mutual funds)2020-12-31$855,338
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2020-12-31No
Was there a failure to transmit to the plan any participant contributions2020-12-31No
Has the plan failed to provide any benefit when due under the plan2020-12-31No
Contributions received in cash from employer2020-12-31$18,664
Employer contributions (assets) at end of year2020-12-31$702
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2020-12-31$131,763
Did the plan have assets held for investment2020-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2020-12-31No
Opinion of an independent qualified public accountant for this plan2020-12-31Unqualified
Accountancy firm name2020-12-31CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN2020-12-31222428965
2019 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$9,132
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$9,132
Total income from all sources (including contributions)2019-12-31$1,790,961
Total income from all sources (including contributions)2019-12-31$1,790,961
Total loss/gain on sale of assets2019-12-31$0
Total loss/gain on sale of assets2019-12-31$0
Total of all expenses incurred2019-12-31$946,597
Total of all expenses incurred2019-12-31$946,597
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$914,857
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$914,857
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$779,314
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$779,314
Value of total assets at end of year2019-12-31$5,368,079
Value of total assets at end of year2019-12-31$5,368,079
Value of total assets at beginning of year2019-12-31$4,532,847
Value of total assets at beginning of year2019-12-31$4,532,847
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$31,740
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$31,740
Total interest from all sources2019-12-31$5,199
Total interest from all sources2019-12-31$5,199
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$160,277
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$160,277
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$160,277
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$160,277
Was this plan covered by a fidelity bond2019-12-31Yes
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$500,000
Value of fidelity bond cover2019-12-31$500,000
If this is an individual account plan, was there a blackout period2019-12-31No
If this is an individual account plan, was there a blackout period2019-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2019-12-31$0
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$362,655
Contributions received from participants2019-12-31$362,655
Participant contributions at end of year2019-12-31$120,609
Participant contributions at end of year2019-12-31$120,609
Participant contributions at beginning of year2019-12-31$131,588
Participant contributions at beginning of year2019-12-31$131,588
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$399,004
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$399,004
Value of other receiveables (less allowance for doubtful accounts) at end of year2019-12-31$1,245
Value of other receiveables (less allowance for doubtful accounts) at end of year2019-12-31$1,245
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2019-12-31$1,870
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2019-12-31$1,870
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2019-12-31$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2019-12-31$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2019-12-31$9,132
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2019-12-31$9,132
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$844,364
Value of net income/loss2019-12-31$844,364
Value of net assets at end of year (total assets less liabilities)2019-12-31$5,368,079
Value of net assets at end of year (total assets less liabilities)2019-12-31$5,368,079
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$4,523,715
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$4,523,715
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Investment advisory and management fees2019-12-31$31,740
Investment advisory and management fees2019-12-31$31,740
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$4,725,686
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$4,725,686
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$3,775,803
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$3,775,803
Income. Interest from loans (other than to participants)2019-12-31$5,199
Income. Interest from loans (other than to participants)2019-12-31$5,199
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2019-12-31$520,539
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2019-12-31$520,539
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2019-12-31$623,586
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2019-12-31$623,586
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2019-12-31$623,586
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2019-12-31$623,586
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$846,171
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$846,171
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$17,655
Contributions received in cash from employer2019-12-31$17,655
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$914,857
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$914,857
Did the plan have assets held for investment2019-12-31Yes
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm name2019-12-31CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN2019-12-31222428965
Accountancy firm EIN2019-12-31222428965
2018 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets2018-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$9,132
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$6,599
Total income from all sources (including contributions)2018-12-31$153,508
Total loss/gain on sale of assets2018-12-31$0
Total of all expenses incurred2018-12-31$539,142
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2018-12-31$505,503
Total contributions o plan (from employers,participants, others, non cash contrinutions)2018-12-31$428,628
Value of total assets at end of year2018-12-31$4,532,847
Value of total assets at beginning of year2018-12-31$4,915,948
Total of administrative expenses incurred including professional, contract, advisory and management fees2018-12-31$33,639
Total interest from all sources2018-12-31$4,153
Total dividends received (eg from common stock, registered investment company shares)2018-12-31$189,845
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2018-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2018-12-31$189,845
Was this plan covered by a fidelity bond2018-12-31Yes
Value of fidelity bond cover2018-12-31$500,000
If this is an individual account plan, was there a blackout period2018-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2018-12-31$0
Were there any nonexempt tranactions with any party-in-interest2018-12-31No
Contributions received from participants2018-12-31$393,293
Participant contributions at end of year2018-12-31$131,588
Participant contributions at beginning of year2018-12-31$80,644
Income. Received or receivable in cash from other sources (including rollovers)2018-12-31$14,987
Value of other receiveables (less allowance for doubtful accounts) at end of year2018-12-31$1,870
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2018-12-31$2,072
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2018-12-31$9,132
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2018-12-31$6,599
Other income not declared elsewhere2018-12-31$4,157
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Value of net income/loss2018-12-31$-385,634
Value of net assets at end of year (total assets less liabilities)2018-12-31$4,523,715
Value of net assets at beginning of year (total assets less liabilities)2018-12-31$4,909,349
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2018-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2018-12-31No
Were any leases to which the plan was party in default or uncollectible2018-12-31No
Investment advisory and management fees2018-12-31$33,639
Value of interest in registered invesment companies (eg mutual funds) at end of year2018-12-31$3,775,803
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2018-12-31$4,109,881
Interest on participant loans2018-12-31$4,153
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2018-12-31$623,586
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2018-12-31$723,351
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2018-12-31$723,351
Net investment gain/loss from registered investment companies (e.g. mutual funds)2018-12-31$-473,275
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2018-12-31No
Was there a failure to transmit to the plan any participant contributions2018-12-31No
Has the plan failed to provide any benefit when due under the plan2018-12-31No
Contributions received in cash from employer2018-12-31$20,348
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2018-12-31$505,503
Did the plan have assets held for investment2018-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2018-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2018-12-31Yes
Opinion of an independent qualified public accountant for this plan2018-12-31Disclaimer
Accountancy firm name2018-12-31CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN2018-12-31222428965
2017 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets2017-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$6,599
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$3,810
Total income from all sources (including contributions)2017-12-31$1,002,307
Total loss/gain on sale of assets2017-12-31$0
Total of all expenses incurred2017-12-31$187,654
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2017-12-31$157,832
Total contributions o plan (from employers,participants, others, non cash contrinutions)2017-12-31$395,090
Value of total assets at end of year2017-12-31$4,915,948
Value of total assets at beginning of year2017-12-31$4,098,506
Total of administrative expenses incurred including professional, contract, advisory and management fees2017-12-31$29,822
Total interest from all sources2017-12-31$3,257
Total dividends received (eg from common stock, registered investment company shares)2017-12-31$131,822
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2017-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2017-12-31$131,822
Administrative expenses professional fees incurred2017-12-31$29,822
Was this plan covered by a fidelity bond2017-12-31Yes
Value of fidelity bond cover2017-12-31$500,000
If this is an individual account plan, was there a blackout period2017-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2017-12-31$0
Were there any nonexempt tranactions with any party-in-interest2017-12-31No
Contributions received from participants2017-12-31$377,174
Participant contributions at end of year2017-12-31$80,644
Participant contributions at beginning of year2017-12-31$70,111
Value of other receiveables (less allowance for doubtful accounts) at end of year2017-12-31$2,072
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2017-12-31$1,853
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2017-12-31$6,599
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2017-12-31$3,810
Other income not declared elsewhere2017-12-31$472,138
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Value of net income/loss2017-12-31$814,653
Value of net assets at end of year (total assets less liabilities)2017-12-31$4,909,349
Value of net assets at beginning of year (total assets less liabilities)2017-12-31$4,094,696
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2017-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2017-12-31No
Were any leases to which the plan was party in default or uncollectible2017-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2017-12-31$4,109,881
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2017-12-31$3,376,374
Interest on participant loans2017-12-31$3,257
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2017-12-31$723,351
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2017-12-31$650,168
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2017-12-31$650,168
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2017-12-31No
Was there a failure to transmit to the plan any participant contributions2017-12-31No
Has the plan failed to provide any benefit when due under the plan2017-12-31No
Contributions received in cash from employer2017-12-31$17,916
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2017-12-31$157,832
Did the plan have assets held for investment2017-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2017-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2017-12-31Yes
Opinion of an independent qualified public accountant for this plan2017-12-31Disclaimer
Accountancy firm name2017-12-31CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN2017-12-31222428965
2016 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets2016-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$3,810
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total income from all sources (including contributions)2016-12-31$668,040
Total loss/gain on sale of assets2016-12-31$0
Total of all expenses incurred2016-12-31$178,084
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2016-12-31$152,019
Total contributions o plan (from employers,participants, others, non cash contrinutions)2016-12-31$369,311
Value of total assets at end of year2016-12-31$4,098,506
Value of total assets at beginning of year2016-12-31$3,604,740
Total of administrative expenses incurred including professional, contract, advisory and management fees2016-12-31$26,065
Total interest from all sources2016-12-31$3,270
Total dividends received (eg from common stock, registered investment company shares)2016-12-31$112,052
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2016-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2016-12-31$112,052
Administrative expenses professional fees incurred2016-12-31$26,065
Was this plan covered by a fidelity bond2016-12-31Yes
Value of fidelity bond cover2016-12-31$500,000
If this is an individual account plan, was there a blackout period2016-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2016-12-31$0
Were there any nonexempt tranactions with any party-in-interest2016-12-31No
Contributions received from participants2016-12-31$334,482
Participant contributions at end of year2016-12-31$70,111
Participant contributions at beginning of year2016-12-31$95,303
Participant contributions at beginning of year2016-12-31$16,233
Income. Received or receivable in cash from other sources (including rollovers)2016-12-31$17,914
Value of other receiveables (less allowance for doubtful accounts) at end of year2016-12-31$1,853
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2016-12-31$742
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2016-12-31$3,810
Other income not declared elsewhere2016-12-31$183,407
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Value of net income/loss2016-12-31$489,956
Value of net assets at end of year (total assets less liabilities)2016-12-31$4,094,696
Value of net assets at beginning of year (total assets less liabilities)2016-12-31$3,604,740
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2016-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2016-12-31No
Were any leases to which the plan was party in default or uncollectible2016-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2016-12-31$3,376,374
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2016-12-31$3,100,181
Interest on participant loans2016-12-31$3,270
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2016-12-31$650,168
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2016-12-31$391,470
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2016-12-31$391,470
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2016-12-31No
Was there a failure to transmit to the plan any participant contributions2016-12-31No
Has the plan failed to provide any benefit when due under the plan2016-12-31No
Contributions received in cash from employer2016-12-31$16,915
Employer contributions (assets) at beginning of year2016-12-31$811
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2016-12-31$152,019
Did the plan have assets held for investment2016-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2016-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2016-12-31Yes
Opinion of an independent qualified public accountant for this plan2016-12-31Disclaimer
Accountancy firm name2016-12-31CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN2016-12-31222428965
2015 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets2015-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total income from all sources (including contributions)2015-12-31$532,105
Total loss/gain on sale of assets2015-12-31$0
Total of all expenses incurred2015-12-31$106,120
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2015-12-31$82,448
Total contributions o plan (from employers,participants, others, non cash contrinutions)2015-12-31$551,022
Value of total assets at end of year2015-12-31$3,604,740
Value of total assets at beginning of year2015-12-31$3,178,755
Total of administrative expenses incurred including professional, contract, advisory and management fees2015-12-31$23,672
Total interest from all sources2015-12-31$3,720
Total dividends received (eg from common stock, registered investment company shares)2015-12-31$134,514
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2015-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2015-12-31$134,514
Administrative expenses professional fees incurred2015-12-31$23,672
Was this plan covered by a fidelity bond2015-12-31Yes
Value of fidelity bond cover2015-12-31$400,000
If this is an individual account plan, was there a blackout period2015-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2015-12-31$0
Were there any nonexempt tranactions with any party-in-interest2015-12-31No
Contributions received from participants2015-12-31$336,326
Participant contributions at end of year2015-12-31$95,303
Participant contributions at beginning of year2015-12-31$75,148
Participant contributions at end of year2015-12-31$16,233
Income. Received or receivable in cash from other sources (including rollovers)2015-12-31$199,063
Value of other receiveables (less allowance for doubtful accounts) at end of year2015-12-31$742
Other income not declared elsewhere2015-12-31$-157,151
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Value of net income/loss2015-12-31$425,985
Value of net assets at end of year (total assets less liabilities)2015-12-31$3,604,740
Value of net assets at beginning of year (total assets less liabilities)2015-12-31$3,178,755
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2015-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2015-12-31No
Were any leases to which the plan was party in default or uncollectible2015-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2015-12-31$3,100,181
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2015-12-31$2,741,927
Interest on participant loans2015-12-31$3,720
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2015-12-31$391,470
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2015-12-31$361,680
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2015-12-31$361,680
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2015-12-31No
Was there a failure to transmit to the plan any participant contributions2015-12-31No
Has the plan failed to provide any benefit when due under the plan2015-12-31No
Contributions received in cash from employer2015-12-31$15,633
Employer contributions (assets) at end of year2015-12-31$811
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2015-12-31$82,448
Did the plan have assets held for investment2015-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2015-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2015-12-31Yes
Opinion of an independent qualified public accountant for this plan2015-12-31Disclaimer
Accountancy firm name2015-12-31YOUNGER & COMPANY, CPAS
Accountancy firm EIN2015-12-31207257034
2014 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets2014-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total income from all sources (including contributions)2014-12-31$530,645
Total loss/gain on sale of assets2014-12-31$0
Total of all expenses incurred2014-12-31$254,355
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2014-12-31$232,189
Value of total corrective distributions2014-12-31$2,441
Total contributions o plan (from employers,participants, others, non cash contrinutions)2014-12-31$356,243
Value of total assets at end of year2014-12-31$3,178,755
Value of total assets at beginning of year2014-12-31$2,902,465
Total of administrative expenses incurred including professional, contract, advisory and management fees2014-12-31$19,725
Total interest from all sources2014-12-31$4,696
Total dividends received (eg from common stock, registered investment company shares)2014-12-31$100,911
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2014-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2014-12-31$100,911
Administrative expenses professional fees incurred2014-12-31$19,725
Was this plan covered by a fidelity bond2014-12-31Yes
Value of fidelity bond cover2014-12-31$300,000
If this is an individual account plan, was there a blackout period2014-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2014-12-31$0
Were there any nonexempt tranactions with any party-in-interest2014-12-31No
Contributions received from participants2014-12-31$328,256
Participant contributions at end of year2014-12-31$75,148
Participant contributions at beginning of year2014-12-31$82,718
Income. Received or receivable in cash from other sources (including rollovers)2014-12-31$13,284
Other income not declared elsewhere2014-12-31$2,800
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Value of net income/loss2014-12-31$276,290
Value of net assets at end of year (total assets less liabilities)2014-12-31$3,178,755
Value of net assets at beginning of year (total assets less liabilities)2014-12-31$2,902,465
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2014-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2014-12-31No
Were any leases to which the plan was party in default or uncollectible2014-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2014-12-31$2,741,927
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2014-12-31$2,509,148
Income. Interest from loans (other than to participants)2014-12-31$4,696
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2014-12-31$361,680
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2014-12-31$310,599
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2014-12-31$310,599
Net investment gain/loss from registered investment companies (e.g. mutual funds)2014-12-31$65,995
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2014-12-31No
Was there a failure to transmit to the plan any participant contributions2014-12-31Yes
Has the plan failed to provide any benefit when due under the plan2014-12-31No
Contributions received in cash from employer2014-12-31$14,703
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2014-12-31$232,189
Did the plan have assets held for investment2014-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2014-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2014-12-31Yes
Opinion of an independent qualified public accountant for this plan2014-12-31Disclaimer
Accountancy firm name2014-12-31YOUNGER & COMPANY, CPAS
Accountancy firm EIN2014-12-31207257034
2013 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets2013-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total income from all sources (including contributions)2013-12-31$517,319
Total loss/gain on sale of assets2013-12-31$0
Total of all expenses incurred2013-12-31$48,524
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$8,525
Value of total corrective distributions2013-12-31$515
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$219,738
Value of total assets at end of year2013-12-31$2,902,465
Value of total assets at beginning of year2013-12-31$2,433,670
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$39,484
Total interest from all sources2013-12-31$3,953
Total dividends received (eg from common stock, registered investment company shares)2013-12-31$67,281
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2013-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2013-12-31$67,281
Administrative expenses professional fees incurred2013-12-31$15,218
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$300,000
If this is an individual account plan, was there a blackout period2013-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2013-12-31$0
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$209,270
Participant contributions at end of year2013-12-31$82,718
Participant contributions at beginning of year2013-12-31$78,298
Participant contributions at end of year2013-12-31$0
Participant contributions at beginning of year2013-12-31$11,756
Other income not declared elsewhere2013-12-31$10,329
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$468,795
Value of net assets at end of year (total assets less liabilities)2013-12-31$2,902,465
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$2,433,670
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Investment advisory and management fees2013-12-31$24,266
Value of interest in registered invesment companies (eg mutual funds) at end of year2013-12-31$2,509,148
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2013-12-31$1,871,771
Income. Interest from loans (other than to participants)2013-12-31$3,952
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2013-12-31$310,599
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2013-12-31$471,257
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2013-12-31$471,257
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2013-12-31$1
Net investment gain/loss from registered investment companies (e.g. mutual funds)2013-12-31$216,018
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31No
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Contributions received in cash from employer2013-12-31$10,468
Employer contributions (assets) at end of year2013-12-31$0
Employer contributions (assets) at beginning of year2013-12-31$588
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$8,525
Did the plan have assets held for investment2013-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2013-12-31No
Opinion of an independent qualified public accountant for this plan2013-12-31Unqualified
Accountancy firm name2013-12-31YOUNGER & COMPANY, CPAS
Accountancy firm EIN2013-12-31207257034
2012 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets2012-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total income from all sources (including contributions)2012-12-31$422,904
Total loss/gain on sale of assets2012-12-31$0
Total of all expenses incurred2012-12-31$108,340
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2012-12-31$59,875
Value of total corrective distributions2012-12-31$14,334
Total contributions o plan (from employers,participants, others, non cash contrinutions)2012-12-31$256,642
Value of total assets at end of year2012-12-31$2,433,670
Value of total assets at beginning of year2012-12-31$2,119,106
Total of administrative expenses incurred including professional, contract, advisory and management fees2012-12-31$34,131
Total interest from all sources2012-12-31$4,077
Total dividends received (eg from common stock, registered investment company shares)2012-12-31$62,157
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2012-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2012-12-31$62,157
Administrative expenses professional fees incurred2012-12-31$12,947
Was this plan covered by a fidelity bond2012-12-31Yes
Value of fidelity bond cover2012-12-31$250,000
If this is an individual account plan, was there a blackout period2012-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2012-12-31$0
Were there any nonexempt tranactions with any party-in-interest2012-12-31No
Contributions received from participants2012-12-31$244,421
Participant contributions at end of year2012-12-31$78,298
Participant contributions at beginning of year2012-12-31$66,492
Participant contributions at end of year2012-12-31$11,756
Participant contributions at beginning of year2012-12-31$7,821
Other income not declared elsewhere2012-12-31$713
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Value of net income/loss2012-12-31$314,564
Value of net assets at end of year (total assets less liabilities)2012-12-31$2,433,670
Value of net assets at beginning of year (total assets less liabilities)2012-12-31$2,119,106
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2012-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2012-12-31No
Were any leases to which the plan was party in default or uncollectible2012-12-31No
Investment advisory and management fees2012-12-31$21,184
Value of interest in registered invesment companies (eg mutual funds) at end of year2012-12-31$1,871,771
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2012-12-31$1,615,681
Interest on participant loans2012-12-31$4,009
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2012-12-31$471,257
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2012-12-31$428,721
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2012-12-31$428,721
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2012-12-31$68
Net investment gain/loss from registered investment companies (e.g. mutual funds)2012-12-31$99,315
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2012-12-31No
Was there a failure to transmit to the plan any participant contributions2012-12-31No
Has the plan failed to provide any benefit when due under the plan2012-12-31No
Contributions received in cash from employer2012-12-31$12,221
Employer contributions (assets) at end of year2012-12-31$588
Employer contributions (assets) at beginning of year2012-12-31$391
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2012-12-31$59,875
Did the plan have assets held for investment2012-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2012-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2012-12-31Yes
Opinion of an independent qualified public accountant for this plan2012-12-31Disclaimer
Accountancy firm name2012-12-31YOUNGER & COMPANY, CPAS
Accountancy firm EIN2012-12-31207257034
2011 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2011 401k financial data
Total income from all sources (including contributions)2011-12-31$301,932
Total of all expenses incurred2011-12-31$73,146
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2011-12-31$29,842
Value of total corrective distributions2011-12-31$12,734
Total contributions o plan (from employers,participants, others, non cash contrinutions)2011-12-31$318,821
Value of total assets at end of year2011-12-31$2,119,106
Value of total assets at beginning of year2011-12-31$1,890,320
Total of administrative expenses incurred including professional, contract, advisory and management fees2011-12-31$30,570
Total interest from all sources2011-12-31$2,166
Total dividends received (eg from common stock, registered investment company shares)2011-12-31$40,772
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2011-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2011-12-31$40,772
Was this plan covered by a fidelity bond2011-12-31Yes
Value of fidelity bond cover2011-12-31$250,000
If this is an individual account plan, was there a blackout period2011-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2011-12-31$0
Were there any nonexempt tranactions with any party-in-interest2011-12-31No
Contributions received from participants2011-12-31$226,496
Participant contributions at end of year2011-12-31$66,492
Participant contributions at beginning of year2011-12-31$21,231
Participant contributions at end of year2011-12-31$7,821
Participant contributions at beginning of year2011-12-31$7,168
Income. Received or receivable in cash from other sources (including rollovers)2011-12-31$81,000
Other income not declared elsewhere2011-12-31$40
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Value of net income/loss2011-12-31$228,786
Value of net assets at end of year (total assets less liabilities)2011-12-31$2,119,106
Value of net assets at beginning of year (total assets less liabilities)2011-12-31$1,890,320
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2011-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2011-12-31No
Were any leases to which the plan was party in default or uncollectible2011-12-31No
Investment advisory and management fees2011-12-31$18,580
Value of interest in registered invesment companies (eg mutual funds) at end of year2011-12-31$1,615,681
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2011-12-31$1,450,171
Interest on participant loans2011-12-31$2,124
Value of interest in common/collective trusts at beginning of year2011-12-31$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2011-12-31$428,721
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2011-12-31$411,392
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2011-12-31$411,392
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2011-12-31$42
Net investment gain/loss from registered investment companies (e.g. mutual funds)2011-12-31$-59,867
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2011-12-31No
Was there a failure to transmit to the plan any participant contributions2011-12-31No
Has the plan failed to provide any benefit when due under the plan2011-12-31No
Contributions received in cash from employer2011-12-31$11,325
Employer contributions (assets) at end of year2011-12-31$391
Employer contributions (assets) at beginning of year2011-12-31$358
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2011-12-31$29,842
Contract administrator fees2011-12-31$11,990
Did the plan have assets held for investment2011-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2011-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2011-12-31No
Opinion of an independent qualified public accountant for this plan2011-12-31Unqualified
Accountancy firm name2011-12-31YOUNGER & COMPANY, CPAS
Accountancy firm EIN2011-12-31207257034
2010 : MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2010 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$5,934
Total income from all sources (including contributions)2010-12-31$402,695
Total of all expenses incurred2010-12-31$220,717
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2010-12-31$188,016
Total contributions o plan (from employers,participants, others, non cash contrinutions)2010-12-31$243,238
Value of total assets at end of year2010-12-31$1,890,320
Value of total assets at beginning of year2010-12-31$1,708,342
Total of administrative expenses incurred including professional, contract, advisory and management fees2010-12-31$32,701
Total interest from all sources2010-12-31$1,427
Total dividends received (eg from common stock, registered investment company shares)2010-12-31$39,908
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2010-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2010-12-31$39,908
Administrative expenses professional fees incurred2010-12-31$32,701
Was this plan covered by a fidelity bond2010-12-31Yes
Value of fidelity bond cover2010-12-31$250,000
If this is an individual account plan, was there a blackout period2010-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2010-12-31$0
Were there any nonexempt tranactions with any party-in-interest2010-12-31No
Contributions received from participants2010-12-31$204,055
Participant contributions at end of year2010-12-31$21,231
Participant contributions at beginning of year2010-12-31$21,086
Participant contributions at end of year2010-12-31$7,168
Income. Received or receivable in cash from other sources (including rollovers)2010-12-31$28,980
Assets. Loans (other than to participants) at end of year2010-12-31$21,231
Assets. Loans (other than to participants) at beginning of year2010-12-31$21,086
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2010-12-31$5,934
Other income not declared elsewhere2010-12-31$6,240
Total non interest bearing cash at end of year2010-12-31$6,531
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Value of net income/loss2010-12-31$181,978
Value of net assets at end of year (total assets less liabilities)2010-12-31$1,890,320
Value of net assets at beginning of year (total assets less liabilities)2010-12-31$1,708,342
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2010-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2010-12-31No
Were any leases to which the plan was party in default or uncollectible2010-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2010-12-31$1,450,171
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2010-12-31$1,256,095
Interest on participant loans2010-12-31$1,423
Value of interest in common/collective trusts at end of year2010-12-31$0
Value of interest in common/collective trusts at beginning of year2010-12-31$274,728
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2010-12-31$411,392
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2010-12-31$156,433
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2010-12-31$156,433
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2010-12-31$4
Net investment gain/loss from registered investment companies (e.g. mutual funds)2010-12-31$111,882
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2010-12-31No
Was there a failure to transmit to the plan any participant contributions2010-12-31No
Has the plan failed to provide any benefit when due under the plan2010-12-31No
Contributions received in cash from employer2010-12-31$10,203
Employer contributions (assets) at end of year2010-12-31$358
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2010-12-31$188,016
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32010-12-31No
Did the plan have assets held for investment2010-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2010-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2010-12-31Yes
Opinion of an independent qualified public accountant for this plan2010-12-31Disclaimer
Accountancy firm name2010-12-31YOUNGER & COMPANY
Accountancy firm EIN2010-12-31204257034

Form 5500 Responses for MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN

2023: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2023 form 5500 responses
2023-01-01Type of plan entitySingle employer plan
2023-01-01Submission has been amendedNo
2023-01-01This submission is the final filingNo
2023-01-01This return/report is a short plan year return/report (less than 12 months)No
2023-01-01Plan is a collectively bargained planNo
2023-01-01Plan funding arrangement – TrustYes
2023-01-01Plan benefit arrangement - TrustYes
2022: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2022 form 5500 responses
2022-01-01Type of plan entitySingle employer plan
2022-01-01Submission has been amendedNo
2022-01-01This submission is the final filingNo
2022-01-01This return/report is a short plan year return/report (less than 12 months)No
2022-01-01Plan is a collectively bargained planNo
2022-01-01Plan funding arrangement – TrustYes
2022-01-01Plan benefit arrangement - TrustYes
2021: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01Submission has been amendedNo
2021-01-01This submission is the final filingNo
2021-01-01This return/report is a short plan year return/report (less than 12 months)No
2021-01-01Plan is a collectively bargained planNo
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement - TrustYes
2020: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2020 form 5500 responses
2020-01-01Type of plan entitySingle employer plan
2020-01-01Submission has been amendedNo
2020-01-01This submission is the final filingNo
2020-01-01This return/report is a short plan year return/report (less than 12 months)No
2020-01-01Plan is a collectively bargained planNo
2020-01-01Plan funding arrangement – TrustYes
2020-01-01Plan benefit arrangement - TrustYes
2019: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Submission has been amendedNo
2019-01-01This submission is the final filingNo
2019-01-01This return/report is a short plan year return/report (less than 12 months)No
2019-01-01Plan is a collectively bargained planNo
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement - TrustYes
2018: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2018 form 5500 responses
2018-01-01Type of plan entitySingle employer plan
2018-01-01Submission has been amendedNo
2018-01-01This submission is the final filingNo
2018-01-01This return/report is a short plan year return/report (less than 12 months)No
2018-01-01Plan is a collectively bargained planNo
2018-01-01Plan funding arrangement – TrustYes
2018-01-01Plan benefit arrangement - TrustYes
2017: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2017 form 5500 responses
2017-01-01Type of plan entitySingle employer plan
2017-01-01Submission has been amendedNo
2017-01-01This submission is the final filingNo
2017-01-01This return/report is a short plan year return/report (less than 12 months)No
2017-01-01Plan is a collectively bargained planNo
2017-01-01Plan funding arrangement – TrustYes
2017-01-01Plan benefit arrangement - TrustYes
2016: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2016 form 5500 responses
2016-01-01Type of plan entitySingle employer plan
2016-01-01Submission has been amendedNo
2016-01-01This submission is the final filingNo
2016-01-01This return/report is a short plan year return/report (less than 12 months)No
2016-01-01Plan is a collectively bargained planNo
2016-01-01Plan funding arrangement – TrustYes
2016-01-01Plan benefit arrangement - TrustYes
2015: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2015 form 5500 responses
2015-01-01Type of plan entitySingle employer plan
2015-01-01Submission has been amendedNo
2015-01-01This submission is the final filingNo
2015-01-01This return/report is a short plan year return/report (less than 12 months)No
2015-01-01Plan is a collectively bargained planNo
2015-01-01Plan funding arrangement – TrustYes
2015-01-01Plan benefit arrangement - TrustYes
2014: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2014 form 5500 responses
2014-01-01Type of plan entitySingle employer plan
2014-01-01Submission has been amendedNo
2014-01-01This submission is the final filingNo
2014-01-01This return/report is a short plan year return/report (less than 12 months)No
2014-01-01Plan is a collectively bargained planNo
2014-01-01Plan funding arrangement – TrustYes
2014-01-01Plan benefit arrangement - TrustYes
2013: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2013 form 5500 responses
2013-01-01Type of plan entitySingle employer plan
2013-01-01Submission has been amendedYes
2013-01-01This submission is the final filingNo
2013-01-01This return/report is a short plan year return/report (less than 12 months)No
2013-01-01Plan is a collectively bargained planNo
2013-01-01Plan funding arrangement – TrustYes
2013-01-01Plan benefit arrangement - TrustYes
2012: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2012 form 5500 responses
2012-01-01Type of plan entitySingle employer plan
2012-01-01Submission has been amendedYes
2012-01-01This submission is the final filingNo
2012-01-01This return/report is a short plan year return/report (less than 12 months)No
2012-01-01Plan is a collectively bargained planNo
2012-01-01Plan funding arrangement – TrustYes
2012-01-01Plan benefit arrangement - TrustYes
2011: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Submission has been amendedYes
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement - TrustYes
2009: MEDICAL PRODUCTS LABORATORIES, INC. 401(K) PROFIT SHARING PLAN 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement - TrustYes

Potentially related plans

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S1